This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
I have read Adam Fein’s Drug Channels blog for about a decade now. source material in his blog, a person can become quite well-informed about the pharmacy industry. For example, “In the compounding period of 1941, the average pharmacy filled about 5,000 prescriptions a year, approximately 15 a day.”
We’ve expressed our own strong opinions on the topic in several blog posts, including this one. Given that, why would a drug company want to reimburse the price of a 340B-covered specialty drug costing tens of thousands of dollars, if the provider isn’t dispensing it correctly and the patient doesn’t benefit?
We’ve expressed our own strong opinions on the topic in several blog posts, including this one. Given that, why would a drug company want to reimburse the price of a 340B-covered specialty drug costing tens of thousands of dollars, if the provider isn’t dispensing it correctly and the patient doesn’t benefit?
The manufacturer’s agreement must cover all its labeler codes that contain an applicable drug or a selected drug. The primary manufacturer of a selected drug may also request CMS to terminate its agreement if they are unwilling to participate in the Medicare DrugPrice Negotiation.
At the same time, we see our neighbors complain about rising drugprices, and the rising cost of health insurance: Restaurateurs complain a lot about GrubHub and their seller fees, their menu stealing, and their ghost kitchens. I’d like to read a few excerpts from his recent blog posts. We complain about DIR fees.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content